| Target Price | $28.56 |
| Price | $17.10 |
| Potential |
67.02%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Surgery Partners, Inc. 2026 .
The average Surgery Partners, Inc. target price is $28.56.
This is
67.02%
register free of charge
$37.80
121.05%
register free of charge
$20.20
18.13%
register free of charge
|
|
| A rating was issued by 18 analysts: 14 Analysts recommend Surgery Partners, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surgery Partners, Inc. stock has an average upside potential 2026 of
67.02%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.11 | 3.42 |
| 13.52% | 9.78% | |
| EBITDA Margin | 20.13% | 16.92% |
| 3.61% | 15.95% | |
| Net Margin | -5.40% | 3.29% |
| 1,144.32% | 160.95% |
14 Analysts have issued a sales forecast Surgery Partners, Inc. 2025 . The average Surgery Partners, Inc. sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Surgery Partners, Inc. EBITDA forecast 2025. The average Surgery Partners, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Surgery Partners, Inc. Analysts have issued a net profit forecast 2025. The average Surgery Partners, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.33 | 0.88 |
| 1,377.78% | 166.17% | |
| P/E | 19.51 | |
| EV/Sales | 1.62 |
14 Analysts have issued a Surgery Partners, Inc. forecast for earnings per share. The average Surgery Partners, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Surgery Partners, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 21 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 21 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Oct 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


